Treatment beyond progression with nivolumab (nivo in patients (pts) with advanced renal cell carcinoma (aRCC) in the phase III CheckMate 025 study.

被引：2

作者：

Escudier, Bernardi.

Motzer, Roberti.

Sharma, Padmanee

Wagstaff, John

Plimack, Elizabeth R.

Hammers, Hans J.

Donskov, Frede

Gurney, Howard

Sosman, Jeffrey Alan

Zalewski, Pawel

Harmenberg, Ulrika

McDermott, David F.

Choueiri, Toni K.

Richardet, Martin Eduardo

Tomita, Yoshihiko

Ravaud, Alain

Doan, Justin

Zhao, Huanyu

Hardy, Helene

George, Saby

机构：

[1] Inst Gustave Roussy, Dept Canc Med, Villejuif, France

[2] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA

[3] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[4] South West Wales Canc Inst, Swansea, England

[5] Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA

[6] Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Baltimore, MD USA

[7] Aarhus Univ Hosp, Aarhus, Denmark

[8] Westmead Hosp, Westmead, NSW, Australia

[9] Vanderbilt Ingram Canc Ctr, Nashville, TN USA

[10] Lakeridge Hlth, Oshawa, ON, Canada

[11] Karolinska Univ Hosp, Stockholm, Sweden

[12] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA

[13] Dana Farber Brigham & Womens Canc Ctr, Boston, MA USA

[14] Oncol Inst Cordoba, Cordoba, Argentina

[15] Niigata Univ, Sch Med, Niigata, Japan

[16] CHU Bordeaux, Hop St Andre, Bordeaux, France

[17] Bristol Myers Squibb, Wallingford, CT USA

[18] Bristol Myers Sqiubb, Princeton, NJ USA

[19] Bristol Myers Squibb, Lawrenceville, NJ USA

[20] Roswell Pk Canc Inst, Buffalo, NY 14263 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期

关键词：

D O I：

10.1200/JCO.2016.34.15_suppl.4509

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

4509

引用

页数：2